Thumbnail Image
Publication

Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer.

Thompson, C
; 
Joseph, N
; ; 
Logue, John P
; 
Wylie, James P
; ; 
Lyons, Jeanette
; 
Anandadas, Carmel N
; 
Citations
Altmetric:
Abstract
The aim of this study is to assess the tolerability of concurrent chemoradiation therapy with gemcitabine (GemX) in muscle invasive bladder cancer following neoadjuvant chemotherapy (neoGemX) by use of patient- and provider-reported outcomes.
Authors
Thompson, C
Joseph, N
Sanderson, Benjamin
Logue, John P
Wylie, James P
Elliott, Tony
Lyons, Jeanette
Anandadas, Carmel N
Choudhury, Ananya
Affiliation
University Hospitals of Morecambe Bay, Lancaster, UK; Rosemere Cancer Centre, Preston
Description
Date
2017-03-15
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
From UNPAYWALL
Adobe PDF, 1.75 MB
Keywords
Type
Article
Citation
Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer. 2017, 97 (4):732-739 Int. J. Radiat Oncol Biol Phys
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/620222
Embedded videos